INTRODUCTION: The aim of the study was to investigate current practice and policies of therapeutic drug monitoring (TDM) service requesting and result reporting in Czechia and Slovakia. MATERIALS AND METHODS: All 149 laboratories that measure plasma drug concentrations were given an online questionnaire during a regular external quality assessment TDM cycle. The questionnaire consisted of 17 questions. The optimal TDM practice was defined as the application of all elements (age, body weight, time of sampling, date of the first administration, time of the last dose administration, the dose, the dosing interval, the route of administration, information on reason of testing, and information on other co-administered drugs) needed for reporting a recommendation for further drug dosing (positive response to question number 16). RESULTS: The response rate was 69%, 103 out of 149 laboratories measuring drug concentrations. Only 12% (12 out of 103 laboratories) of the laboratories implemented all elements needed for optimal TDM practice and reported a recommendation. Both paper and electronic request forms were used by 77 out of 103 (75%) laboratories. A total of 69 out of 103 laboratories (67%) specified the type of sampling tube on their request form. Cystatin C was used for prediction of renal drug elimination by 24% (25 out of 103) of participants. CONCLUSIONS: Small number of laboratories implemented all elements needed for optimal TDM practice and report a recommendation on further dosing. Further efforts in education on optimal TDM practice as well as harmonization of service are desirable.

Department of Clinical Biochemistry and Pharmacology Tomas Bata Hospital Zlín Czech Republic

Institute of Clinical Biochemistry and Diagnostics Medical Faculty in Hradec Králové Charles University Prague Czech Republic

Institute of Environmental and Chemical Engineering University of Pardubice Czech Republic

SEKK spol s r o Pardubice Czech Republic

Zobrazit více v PubMed

Leung D, Ensom MHH, Carr R. Survey of Therapeutic Drug Monitoring Practices in Pediatric Health Care Programs across Canada. Can J Hosp Pharm. 2019;72:126–32. 10.4212/cjhp.v72i2.2882 PubMed DOI PMC

Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. Pharmacopsychiatry. 2018;51:9–62. 10.1055/s-0043-116492 PubMed DOI

Salek T, Vodicka M, Gabrhelik T. Estimated glomerular filtration rate in patients overdosed with gentamicin. J Lab Med. 2020;44:35–9. 10.1515/labmed-2019-0124 DOI

Tate JR, Johnson R, Legg M. Harmonisation of laboratory testing. Clin Biochem Rev. 2012;33:81–4. PubMed PMC

Lippi G, Plebani M. Integrated diagnostics: the future of laboratory medicine? Biochem Med (Zagreb). 2020;30:010501. 10.11613/BM.2020.010501 PubMed DOI PMC

Castello LM, Negro S, Santi F, Zanotti I, Vidali M, Bagnati M, et al. Accidental digitoxin intoxication: an interplay between laboratory and clinical medicine. Biochem Med (Zagreb). 2012;22:380–4. 10.11613/BM.2012.040 PubMed DOI PMC

Tomáš Š, Bedřich F, Josef K, Květa P, Marek B. Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia. Biochem Med (Zagreb). 2019;29:030704. 10.11613/BM.2019.030704 PubMed DOI PMC

Radišić Biljak V, Grubb A, Guerra IC, Cavalier E, Raymondo S, et al. The first step in creating national Chronic Kidney Disease (CKD) guidelines – a questionnaire. Biochem Med (Zagreb). 2019;29:030301. 10.11613/BM.2019.030301 PubMed DOI PMC

Vecellio E, Maley MW, Toouli G, Georgiou A, Westbrook J. Data Quality Associated with Handwritten Laboratory Test Requests: Classification and Frequency of Data-Entry Errors for Outpatient Serology Tests. Health Inf Manag. 2015;44:7–12. 10.1177/183335831504400302 PubMed DOI

Dikmen ZG, Pinar A, Akbiyik F. Specimen rejection in laboratory medicine: Necessary for patient safety? Biochem Med (Zagreb). 2015;25:377–85. 10.11613/BM.2015.037 PubMed DOI PMC

Kang J-S, Lee M-H. Overview of Therapeutic Drug Monitoring. Korean J Intern Med. 2009;24:1–10. 10.3904/kjim.2009.24.1.1 PubMed DOI PMC

Al-Sulaiti FK, Nader AM, Saad MO, Shaukat A, Parakadavathu R, Elzubair A, et al. Clinical and Pharmacokinetic Outcomes of Peak–Trough-Based Versus Trough-Based Vancomycin Therapeutic Drug Monitoring Approaches: A Pragmatic Randomized Controlled Trial. Eur J Drug Metab Pharmacokinet. 2019;44:639–52. 10.1007/s13318-019-00551-1 PubMed DOI PMC

Yoon S, Park KR, Lee S, Song S-H, Park WB, Jang I-J, et al. Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram. Basic Clin Pharmacol Toxicol. 2018;122:233–8. 10.1111/bcpt.12873 PubMed DOI

Kacirova I, Grundmann M, Kolek M, Vyskocilova-Hrudikova E, Urinovska R, Handlos P. Lethal suicide attempt with a mixed-drug intoxication of metoprolol and propafenone – A first pediatric case report. Forensic Sci Int. 2017;278:e34–40. 10.1016/j.forsciint.2017.06.025 PubMed DOI

Grundmann M, Koristkova B, Brozmanova H, Kacirova I. Lamotrigine Drug Interactions in Combination Therapy and the Influence of Therapeutic Drug Monitoring on Clinical Outcomes of Adult Patients. Ther Drug Monit. 2017;39:543–9. 10.1097/FTD.0000000000000433 PubMed DOI

Barreto EF, Rule AD, Murad MH, Kashani KB, Lieske JC, Erwin PJ, et al. Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review. Mayo Clin Proc. 2019;94:500–14. 10.1016/j.mayocp.2018.08.002 PubMed DOI

Grubb A. Cystatin C is Indispensable for Evaluation of Kidney Disease [Electronic version]. EJIFCC. 2017;28:268–76. PubMed PMC

Grundmann M, Kacirova I, Urinovska R. Therapeutic drug monitoring of atypical antipsychotic drugs. Acta Pharm. 2014;64:387–401. 10.2478/acph-2014-0036 PubMed DOI

Plebani M, Astion ML, Barth JH, Chen W, de Oliveira CA, Ibarz Escuer M, et al. Harmonization of quality indicators in laboratory medicine: a preliminary consensus. Clin Chem Lab Med. 2014;52:951–8. 10.1515/cclm-2014-0142 PubMed DOI

TDM of Aminoglycoside Antibiotics and Vancomycin as an Indicator of the Quality of Medical Care: Results of the 7-Years Monitoring. Available at: https://www.clinicaltherapeutics.com/article/S0149-2918(17)30554-4/fulltext. Accessed February 15th 2020.

Cystatin C for gentamicin dosing - a case study